Voyager Therapeutics: Q3 Earnings Snapshot
In this article:
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Voyager Therapeutics Inc. (VYGR) on Monday reported a loss of $25.9 million in its third quarter.
The Cambridge, Massachusetts-based company said it had a loss of 59 cents per share.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 58 cents per share.
The gene therapy company posted revenue of $4.6 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VYGR at https://www.zacks.com/ap/VYGR
